The innovative drug internationalization theme hasn't truly cooled down this year. $INNOGEN-B(02591.HK), $Beigene(ONC.US), $CSTONE PHARMA-B(02616.HK), and $SBP GROUP(01177.HK) have all emerged together, and the sparks in the sector are starting to fly again.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments